NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum
NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum GlobeNewswire September 24, 2025 NAARDEN, The Netherlands and MIAMI, Sept. 24, 2025 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with […]